Spruce Biosciences downgraded to Market Perform from Outperform at JMP
PremiumThe FlySpruce Biosciences downgraded to Market Perform from Outperform at JMP
4M ago
Spruce Biosciences Inc trading resumes
Premium
The Fly
Spruce Biosciences Inc trading resumes
4M ago
Spruce Biosciences Inc trading halted, news pending
Premium
The Fly
Spruce Biosciences Inc trading halted, news pending
4M ago
Spruce Biosciences reports Q3 EPS (21c), consensus (24c)
PremiumThe FlySpruce Biosciences reports Q3 EPS (21c), consensus (24c)
5M ago
Competitor disappointments bode well for Neurocrine, says BofA
Premium
The Fly
Competitor disappointments bode well for Neurocrine, says BofA
7M ago
Spruce Biosciences reports Q2 EPS (22c), consensus (32c)
Premium
The Fly
Spruce Biosciences reports Q2 EPS (22c), consensus (32c)
8M ago
Spruce Biosciences announces upcoming poster presentation
PremiumThe FlySpruce Biosciences announces upcoming poster presentation
12M ago
Spruce Biosciences’ Compliance Hurdle: Navigating Sarbanes-Oxley to Protect Market Value
Premium
Company Announcements
Spruce Biosciences’ Compliance Hurdle: Navigating Sarbanes-Oxley to Protect Market Value
1y ago
Spruce Biosciences downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Spruce Biosciences downgraded to Neutral from Buy at H.C. Wainwright
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100